A Study to Test the Effects of Itraconazole and Carbamazepine on OPC-167832 in Healthy Men and Women
1期
已完成
NCT07542847
| 适应症 | Healthy Volunteers |
|---|
| 分期 | 1期 |
|---|
| 申办方 | Otsuka Pharmaceutical Development & Commercialization, Inc. |
|---|
| 状态 | 已完成 |
|---|
| 受试者人数 | 24 人 |
|---|
| 干预（药物） | OPC-167832, Itraconazole, Carbamazepine |
|---|
| 开始日期 | 2022年9月19日 |
|---|
| 完成日期 | 2022年11月18日 |
|---|
| 结果公布日 | 2026年6月5日 |
|---|
摘要
The purpose of this trial is to assess the potential for cytochrome P450 (CYP)-mediated drug-drug interactions (DDIs) with OPC-167832. The study is conducted in 2 parts: Part 1 assesses the potential effect of the CYP3A inhibitor itraconazole on the metabolism of OPC-167832 and Part 2 assesses the potential effect of the CYP3A inducer carbamazepine on the metabolism of OPC-167832 in healthy adult participants.
Part 1: Maximum Plasma Concentration (Cmax) of OPC-167832
Predose and up to 168 hours postdose on Day 1; and Predose and up to 264 hours postdose on Day 15. · nanograms per milliliter (ng/mL)
| OPC-167832 | 81.0 ± 29.3 nanograms per milliliter (ng/mL) |
|---|
| OPC-167832 and Itraconazole | 144 ± 66.7 nanograms per milliliter (ng/mL) |
|---|
| Geometric Mean Ratio (GMR) | 1.723 (95% CI 1.410–2.106) |
|---|
Part 2: Cmax of OPC-167832
Predose and up to 168 hours postdose on Day 1; and Predose and up to 168 hours postdose on Day 25. · ng/mL
| OPC-167832 | 95.1 ± 36.6 ng/mL |
|---|
| OPC-167832 and Carbamazepine | 95.8 ± 32.9 ng/mL |
|---|
| GMR | 1.07 (95% CI 0.926–1.236) |
|---|
Part 1: Area Under the Concentration-time Curve Calculated to the Last Observable Concentration at Time t (AUCt) of OPC-167832
Predose and up to 168 hours postdose on Day 1; and Predose and up to 264 hours postdose on Day 15. · Nanograms*hours per milliliter (ng*h/mL)
| OPC-167832 | 2310 ± 898 Nanograms*hours per milliliter (ng*h/mL) |
|---|
| OPC-167832 and Itraconazole | 4490 ± 2390 Nanograms*hours per milliliter (ng*h/mL) |
|---|
| GMR | 1.82 (95% CI 1.568–2.113) |
|---|
在 BENITIONS 中查看
查看 ClinicalTrials.gov 原文
全部试验
本页整理自 ClinicalTrials.gov 的公开数据，不构成医疗建议，也不构成投资建议。请务必咨询专业医师。